EUVIMEDEUVIMED entdecken
Crossref

Bioinformatics-Key to Drug Discovery and Development

Reddy MA

Open Access Journal of Pharmaceutical Research · 2017

DOI: 10.23880/oajpr-16000126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Access Journal of Pharmaceutical Research, 2017. Verfasst von Reddy MA. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug discovery and development is a complex, high risk, time consuming and potentially highly rewarding process. Pharmaceutical companies are spending millions of dollar per drug to bring it to the market. The development of a new drug requires a technological expertise, human resources and huge capital investment. It also requires strict adherence to regulations on testing and manufacturing standards before a new drug comes into market and can be used in the general population, in fact, some time it fails to come into market. All these factors just increase the cost for a new chemical entity research and development. Bioinformatics in drug designing process made positive effect on overall process and can accelerate various steps of drug designing, and reduce the cost and over all time. Current note focuses on the role of bioinformatics in drug discovery and development process.

Zitieren

APA

MA, R. (2017). Bioinformatics-Key to Drug Discovery and Development. Open Access Journal of Pharmaceutical Research. https://doi.org/10.23880/oajpr-16000126

Vancouver

MA R. Bioinformatics-Key to Drug Discovery and Development. Open Access Journal of Pharmaceutical Research. 2017. doi:10.23880/oajpr-16000126

BibTeX
@article{MA2017,
  author = {MA, Reddy},
  title = {Bioinformatics-Key to Drug Discovery and Development},
  journal = {Open Access Journal of Pharmaceutical Research},
  year = {2017},
  doi = {10.23880/oajpr-16000126}
}
Kostenlos starten →